CardioGenics Holdings (CardioGenics Holdings) Selling, General, & Admin. Expense : $0.55 Mil (TTM As of Jan. 2016)

CardioGenics Holdings Selling, General, & Admin. Expense Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Selling, General, & Admin. Expense		Get a 7-Day Free Trial					5.15	0.74	1.89	0.45	0.54

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Selling, General, & Admin. Expense	Get a 7-Day Free Trial															0.13	0.08	0.05	0.28	0.14

Competitive Comparison of CardioGenics Holdings's Selling, General, & Admin. Expense

For the Diagnostics & Research subindustry, CardioGenics Holdings's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Selling, General, & Admin. Expense Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Selling, General, & Admin. Expense falls into.

CardioGenics Holdings Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings  (OTCPK:CGNH) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.

CardioGenics Holdings Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description